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INTRODUCTION
Inhaled administration of test materials to animals has technical challenges for quantitative 
dosimetry. Inhaled “doses” reported in non-clinical studies are often calculated using an equation 
such as that of Alexander et al. [1] to estimate the respired minute volume (eRMV) from body 
weight data. This approach may overlook physiological effects on lung function associated with a 
formulation’s properties or habituation of animals to the “dosing” technique. Rats are insensitive 
to red light [2] and anecdotal data (unpublished) suggested red lighting may induce a calmer state 
in restrained rats. We hypothesized that the lighting color (red or white) and duration of restraint 
tube acclimation protocols may influence the breath frequency and minute volume of rats during 
inhalation exposure, representing a potential source of variability in achieved doses. Head-out 
plethysmography [3] was used to investigate this hypothesis concurrent with inhaled administra-
tion of an anti-inflammatory drug.
METHODS
Male rats (Crl:WI(Han); n=8 per group; 11 weeks old) were acclimatized to restraint tubes for 
two or six days and administered a single inhaled “dose” (600 µg/kg; one hour exposure) of an 
anti-inflammatory drug under either normal fluorescent lighting or red-filtered lighting (λ≥600 nm). 
Rats were acclimatized by progressively increasing the period of tube restraint each day, up to a 
maximum of one hour; rats acclimatized over six days were first subjected to a neck-seal on the 
fourth day of tube restraint. The micronized drug, 5% (w/w) in lactose, was dispersed into a flow-
through chamber using a Wright dust feed [4]. Rats were assessed for breath frequency (BF) and 
minute volume (MV) by head-out plethysmography during the snout-only inhalation exposure 
and euthanized immediately post-dose and sampled for drug analysis of lung homogenate (right and 
intermediate lobes pooled) by high performance liquid chromatography with mass spectrometry 
detection (HPLC-MS/MS).
For each rat, a mean BF and MV was calculated for the one hour exposure period and for 
five minute periods ending 5, 15, 30, 45, and 60 minutes from the start of exposure. Statistical analysis 
 (2-way analysis of variance; ANOVA) was applied to the mean of animal-specific means pooled 
for acclimation periods or lighting conditions (n=16). A Latin square design was used for statisti-
cal analyses (2-way ANOVA) of acclimation period (red and white light data pooled) and lighting 
(two-day and six-day acclimation protocols pooled).
RESULTS
BF and MV of rats during exposure were not affected by their illumination under red or white light. 
There was no statistical difference in mean values for the one hour exposure period (Tables 1 and 2), 
but an initial transient elevation in BF and MV was more pronounced for rats subjected to a two-
day acclimatization protocol, relative to a six-day protocol (Figures 1 and 2). 
Table 1.
Breath frequency (breaths/minute) of rats during a one hour inhalation exposure period.
Figure 1.  Breath frequency during a one hour inhalation exposure period. **p<0.01 for six-day vs two-day 
acclimation protocols at five minutes of exposure. 
Table 2.
Minute volume (mL) of rats during a one hour inhalation exposure period.
Figure 2. Minute volume during a one hour inhalation exposure period. *p<0.05 for six-day vs two-day 
acclimation at five minutes; red vs white light at 30 minutes. 
The measured MV of rats under the conditions of this study (no pre-exposure settling 
period) was generally higher and more variable than the body weight-derived estimate of respired 
minute volume (mean MV ≈ 1.17x eRMV) suggesting a lack of relationship between body weight 
and MV, or a potential for eRMV to underestimate the “achieved inhaled dose” (Figure 3, Table 3).
Figure 3. Comparison of the minute volume (MV; measured by head-out plethysmography) and body 
weight-derived respired minute volume (eRMV).
Table 3.
Comparison of measured and body weight-derived estimates of the minute volume (mL)  
of rats during a one hour inhalation exposure period.
Drug-lung homogenate concentrations (Table 4) were more variable than BF and MV. 
An apparent difference in lung concentrations for red versus white lighting was not corroborated 
by a similar trend in MV (Table 2) and hence “achieved lung dose.”
Table 4.
Lung homogenate concentrations (µg/g) for groups and pooled for lighting conditions  
or duration of the acclimation protocol.
CONCLUSIONS
Results of this study suggest a poor relationship between body weight and MV for relatively small 
numbers of animals, or a potential for body weight-derived “dose” estimates to underestimate 
the “achieved inhaled dose.” A more pronounced initial transient elevation of breath frequency 
and MV was evident for rats acclimatized for two days, which could be mitigated if animals are 
allowed to settle before inhalation exposure. MV and BF were unaffected by red or white lighting. 
Measurement of MV during non-clinical inhalation studies may refine anomalies in quantitative 
dosimetry, particularly if respiratory function is affected by treatment. Further work to investigate 
the relationship between measured MV and body weight increases of rats during repeat “dose” 
inhalation studies is ongoing.
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